{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:48:08Z","timestamp":1781592488796,"version":"3.54.5"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s10096-024-04786-y","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T07:02:11Z","timestamp":1708930931000},"page":"1009-1012","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of gradient diffusion and molecular methods using Allplex\u2122 NG&amp;DR assay (Seegene\u00ae) for macrolide and fluoroquinolone screening resistance in Neisseria gonorrhoeae"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1856-1725","authenticated-orcid":false,"given":"Alfredo","family":"Maldonado-Barrueco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Sanz-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iker","family":"Falces-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Garc\u00eda-Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juana","family":"Cacho-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Quiles-Melero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"key":"4786_CR1","doi-asserted-by":"publisher","unstructured":"Unemo M, Lahra MM, Escher M, Eremin S, Cole MJ, Galarza P et al (2021) WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017\u201318: a retrospective observational study. Lancet Microbe 2(11):e627\u2013e636. https:\/\/doi.org\/10.1016\/S2666-5247(21)00171-3","DOI":"10.1016\/S2666-5247(21)00171-3"},{"key":"4786_CR2","doi-asserted-by":"publisher","unstructured":"Kandinov Ilya S, Boris K, Dmitry V, Alexandra G, Sofya K, Alexey et al (2023) Azithromycin susceptibility testing and molecular investigation of Neisseria gonorrhoeae isolates collected in Russia, 2020\u20132021. Antibiotics 12(1):170. https:\/\/doi.org\/10.3390\/antibiotics12010170","DOI":"10.3390\/antibiotics12010170"},{"key":"4786_CR3","doi-asserted-by":"publisher","unstructured":"Beata M-B, Cezary K, Aneta K-U, Marusza Wojciech (2022) Molecular mechanisms of drug resistance and epidemiology of multidrug-resistant variants of Neisseria gonorrhoeae. Int J Mol Sci 23(18):10499. https:\/\/doi.org\/10.3390\/ijms231810499","DOI":"10.3390\/ijms231810499"},{"key":"4786_CR4","doi-asserted-by":"publisher","unstructured":"Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA (2021) Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep 70(4):1\u2013187. https:\/\/doi.org\/10.15585\/mmwr.rr7004a1","DOI":"10.15585\/mmwr.rr7004a1"},{"key":"4786_CR5","doi-asserted-by":"publisher","unstructured":"Helen F, John S, Suneeta S, Tariq SS, FitzGerald Mark (2018) UK national guideline for the management of infection with Neisseria gonorrhoeae. Int J STD AIDS 31(1):4\u201315. https:\/\/doi.org\/10.1177\/0956462419886775","DOI":"10.1177\/0956462419886775"},{"key":"4786_CR6","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez NO, P\u00e9rez NF, Mart\u00ednez SB (2022) Evaluation of the viasure Neisseria gonorrhoeae ciprofloxacin resistant assay for the simultaneous identification and direct detection of ciprofloxacin susceptibility. Diagn Microbiol Infect Dis 104(4):115798. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2022.115798","DOI":"10.1016\/j.diagmicrobio.2022.115798"},{"key":"4786_CR7","doi-asserted-by":"publisher","unstructured":"Maldonado-Barrueco A, Sanz-Gonz\u00e1lez C, Falces-Romero I, Garc\u00eda-Clemente P, Cacho-Calvo J, Quiles-Melero I (2023) Prevalence of mutations associated with macrolide and fluoroquinolone resistance in Neisseria gonorrhoeae with AllplexTM NG&DR Assay (Seegene\u00ae) in a tertiary hospital from Madrid, Spain. Rev Esp Quimioter. https:\/\/doi.org\/10.37201\/req\/058.2023","DOI":"10.37201\/req\/058.2023"},{"key":"4786_CR8","doi-asserted-by":"publisher","unstructured":"Qi C, Stratton CW, Zheng X (2006) Phenotypic testing of bacterial antimicrobial susceptibility. In: Advanced techniques in diagnostic microbiology. Springer, Boston. https:\/\/doi.org\/10.1007\/0-387-32892-0_5","DOI":"10.1007\/0-387-32892-0_5"},{"key":"4786_CR9","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 14.0, (2024) http:\/\/www.eucast.org.n.d"},{"key":"4786_CR10","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez-Bus\u00f3 L, Cole MJ, Spiteri G, Day M, Jacobsson S, Golparian D et al (2022) Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study. Lancet Microbe 3(6):e452\u2013e463. https:\/\/doi.org\/10.1016\/S2666-5247(22)00044-1","DOI":"10.1016\/S2666-5247(22)00044-1"},{"key":"4786_CR11","doi-asserted-by":"publisher","unstructured":"Cobo F, Cabezas-Fern\u00e1ndez MaT, Cabeza-Barrera MaI (2016) Antimicrobial susceptibility and typing of Neisseria gonorrhoeae strains from Southern Spain, 2012\u20132014. Enfermedades Infecciosas y microbiolog\u00eda cl\u00ednica 34(1):3\u20137. https:\/\/doi.org\/10.1016\/j.eimc.2015.01.017","DOI":"10.1016\/j.eimc.2015.01.017"},{"key":"4786_CR12","doi-asserted-by":"publisher","unstructured":"Guerrero-Torres MD, Men\u00e9ndez MB, Guerras CS, Tello E, Ballesteros J, Clavo P et al (2019) Epidemiology, molecular characterisation and antimicrobial susceptibility of Neisseria gonorrhoeae isolates in Madrid, Spain, in 2016. Epidemiol Infect 147:e274. https:\/\/doi.org\/10.1017\/S095026881900150X","DOI":"10.1017\/S095026881900150X"},{"key":"4786_CR13","doi-asserted-by":"publisher","unstructured":"Garc\u00eda UI, Nieto Toboso MC, Azpeitia EM, Imaz Perez M, Hernandez Ragpa L, \u00c1lava Menica JA et al (2020) Epidemiological surveillance study of gonococcal infection in Northern Spain. Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica ;38(2):59\u201364. https:\/\/doi.org\/10.1016\/j.eimc.2019.05.002","DOI":"10.1016\/j.eimc.2019.05.002"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04786-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-024-04786-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04786-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T09:07:36Z","timestamp":1716282456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-024-04786-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["4786"],"URL":"https:\/\/doi.org\/10.1007\/s10096-024-04786-y","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,26]]},"assertion":[{"value":"22 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"Ethical review and approval were not required for the study on human participants in accordance with the local legislation and institutional requirements. The data used are from clinical samples that were necessary for the clinical STI diagnosis of the patients. The detection of resistance associated with macrolide and fluoroquinolone in <i>Neisseria gonorrhoeae<\/i>\u00a0was not incorporated into the medical clinical reports of the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}